BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6476952)

  • 1. Effects of preoperative duration of symptoms on patients with myasthenia gravis.
    Monden Y; Nakahara K; Kagotani K; Fujii Y; Nanjo S; Masaoka A; Kawashima Y
    Ann Thorac Surg; 1984 Sep; 38(3):287-91. PubMed ID: 6476952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunologic role of thymectomy in the treatment of myasthenia gravis: implication of thymus-associated B-lymphocyte subset in reduction of the anti-acetylcholine receptor antibody titer.
    Okumura M; Ohta M; Takeuchi Y; Shiono H; Inoue M; Fukuhara K; Kadota Y; Miyoshi S; Fujii Y; Matsuda H
    J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1922-8. PubMed ID: 14688707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active ectopic thymus predicts poor outcome after thymectomy in class III myasthenia gravis.
    Ambrogi V; Mineo TC
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):601-6. PubMed ID: 22177829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 3. The effect of thymectomy.
    Oosterhuis HJ; Limburg PC; Hummel-Tappel E; Van den Burg W; The TH
    J Neurol Sci; 1985 Jul; 69(3):335-43. PubMed ID: 4031948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seronegative generalized myasthenia gravis: low frequency of thymic pathology.
    Verma PK; Oger JJ
    Neurology; 1992 Mar; 42(3 Pt 1):586-9. PubMed ID: 1296581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thymectomy in Chinese myasthenia gravis].
    Chiu HC; Hsieh JM; Chen RC; Lin FY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):15-22. PubMed ID: 3595261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
    Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
    J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymic abnormalities: antigen or antibody? Response to thymectomy in myasthenia gravis.
    Penn AS; Jaretzki A; Wolff M; Chang HW; Tennyson V
    Ann N Y Acad Sci; 1981; 377():786-804. PubMed ID: 6951500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of thymectomy in myasthenia gravis patients with thymus hyperplasia.
    Yang J; Liu C; Li T; Li C
    Int J Neurosci; 2017 Sep; 127(9):785-789. PubMed ID: 27819773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-acetylcholine-receptor antibody concentrations after thymectomy in patients with myasthenia gravis.
    Seybold ME; Baergen RN; Nave B; Lindstrom JM
    Br Med J; 1978 Oct; 2(6144):1051-3. PubMed ID: 709215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thymic lymphoid hyperplasia of myasthenia gravis patients: correlation with clinical features and efficacy of thymectomy].
    Yoshitake T; Takahama T; Kanai F; Ohnishi K; Tamura K; Suzuki T; Kametani Y; Kataoka D; Nakata H; Itoyama S
    Kyobu Geka; 1995 Jun; 48(6):447-51. PubMed ID: 7602854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of thoracoscopic extended thymectomy for nonthymomatous myasthenia gravis.
    Pompeo E; Tacconi F; Massa R; Mineo D; Nahmias S; Mineo TC
    Eur J Cardiothorac Surg; 2009 Jul; 36(1):164-9. PubMed ID: 19339195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia gravis with thymoma: analysis of and postoperative prognosis for 65 patients with thymomatous myasthenia gravis.
    Monden Y; Nakahara K; Kagotani K; Fujii Y; Masaoka A; Kawashima Y
    Ann Thorac Surg; 1984 Jul; 38(1):46-52. PubMed ID: 6732348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-acetylcholine receptor antibody titer with extended thymectomy in myasthenia gravis.
    Kagotani K; Monden Y; Nakahara K; Fujii Y; Seike Y; Kitamura S; Masaoka A; Kawashima Y
    J Thorac Cardiovasc Surg; 1985 Jul; 90(1):7-12. PubMed ID: 4010323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of patients with Myasthenia gravis from the Henan province, China.
    Gao F; Zhao X; Zhang J; Cui X; Zhang Y; Li Q; Liu P; Fang H; Du Y; Zhang Q; Yang J; Zhang Y
    Muscle Nerve; 2016 May; 53(5):711-6. PubMed ID: 26403759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The outcome of thymectomy in nonthymomatous myasthenia gravis.
    Huang MH; King KL; Hsu WH; Huang BS; Hsu HK; Wang LS; Chien KY
    Surg Gynecol Obstet; 1988 May; 166(5):436-40. PubMed ID: 3363464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do associated auto-antibodies influence the outcome of myasthenia gravis after thymectomy?
    Keijzers M; Damoiseaux J; Vigneron A; Bodart N; Kessels A; Dingemans AM; Hochstenbag M; Maessen J; De Baets M
    Autoimmunity; 2015; 48(8):552-5. PubMed ID: 26226195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic and functional analysis of lymphocytes in myasthenia gravis.
    Levinson AI; Lisak RP; Zweiman B; Kornstein M
    Springer Semin Immunopathol; 1985; 8(3):209-33. PubMed ID: 3901367
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors predicting remission in thymectomized patients with acetylcholine receptor antibody-positive myasthenia gravis.
    Kim H; Lim YM; Lee EJ; Oh YJ; Kim KK
    Muscle Nerve; 2018 Dec; 58(6):796-800. PubMed ID: 30020542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological studies on myasthenia gravis: operative indication and cell-mediated immunity.
    Fukawa M; Torisu M; Miyahara T; Harasaki H; Kai S; Yamamoto H; Konomi K; Nishimura M; Tanaka J
    Surgery; 1978 Mar; 83(3):293-302. PubMed ID: 305125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.